Publications

Liu R, Fan Y, Patel A, Liu H, Du X, Liu B, Di Tanna GL. The association between influenza vaccination, cardiovascular mortality and hospitalization: a living systematic review and prospective meta-analysis. Vaccine 2024 Jan 23. doi: 10.1016/j.vaccine.2024.01.040 (Epub). [Full text]

Patel C, Dey A, Wang H, McIntyre P, Macartney K, Beard F. Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2016-2018 Final Report. Communicable Diseases Intelligence (2018) 2023;47. doi: 10.33321/cdi.2023.47.40. [Full text]

Valeri M, Durrani S, Tran C, Chiu C, Macartney KK, Giles ML, Crawford NW, Australian Technical Advisory Group on Immunisation Atagi Secretariat Immunisation Branch Australian Government. ATAGI 2023 Annual Statement on Immunisation. Communicable Diseases Intelligence (2018) 2023;47. doi: 10.33321/cdi.2023.47.42. [Full text]

Ramsay JA, Jones M, Vande More AM, Hunt SL, Williams PC, Messer M, Wood N, Macartney K, Lee FJ, Britton WJ, Snelling TL, Caterson ID. A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study). Vaccine 2023;41:7250-7258. doi: 10.1016/j.vaccine.2023.10.050. [Full text]

Liu Y, Sánchez-Ovando S, Carolan L, Dowson L, Khvorov A, Jessica Hadiprodjo A, Tseng YY, Delahunty C, Khatami A, Macnish M, Dougherty S, Hagenauer M, Riley KE, Jadhav A, Harvey J, Kaiser M, Mathew S, Hodgson D, Leung V, Subbarao K, Cheng AC, Macartney K, Koirala A, Marshall H, Clark J, Blyth CC, Wark P, Kucharski AJ, Sullivan SG, Fox A. Immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: implications for future pandemic vaccines. Vaccine 2023;41:7192-7200. doi: 10.1016/j.vaccine.2023.10.034. [Full text]

Liu B, Stepien S, Sharma K, Macartney K. Effectiveness of bivalent COVID-19 boosters against COVID-19 mortality in people aged 65 years and older, Australia, November 2022 to May 2023. Eurosurveillance 2023;28:2300603. doi: 10.2807/1560-7917.ES.2023.28.47.2300603. [Full text]

Morris ES, Dey A, Vette K, Rashid H, Wood N, Beard F. Australian vaccine preventable disease epidemiological review series: tetanus 2003-2019. Communicable Diseases Intelligence (2018) 2023;47. doi: 10.33321/cdi.2023.47.61 . [Full text]

Deng L, Lopez L, Glover C, Cashman P, Reynolds R, Macartney K, Wood N. Short-term adverse events following immunization with modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine for Mpox. JAMA 2023;329:2091-2094. doi: 10.1001/jama.2023.7683. [Full text]

Vogt F, Rebuli N, Cretikos M, Liu B, Macartney K, Kaldor J, Wood J. Assessing the effects of SARS-CoV-2 vaccination on the risk of household transmission during delta variant circulation: a population-based data linkage cohort study. The Lancet Regional Health–Western Pacific 2023. doi: 10.1016/j.lanwpc.2023.100930 (Epub). [Full text]

Homaira N, He W-Q, McRae J, Macartney K, Liu B. Coverage and predictors of influenza and pertussis vaccination during pregnancy: a whole of population-based study. Vaccine 2023; 41:6522-6529. doi: 10.1016/j.vaccine.2023.09.008. [Abstract]